Revolution™ Clinical Data

REVOLUTION™ REVEAL Trial

The REVEAL Investigational Device Exemption (IDE) study evaluated the safety and effectiveness of lower extremity arterial atherectomy with the Revolution™ Peripheral Atherectomy System device in 121 ITT subjects with 146 target lesions. The findings confirm a favorable safety and effectiveness profile through 6 months for the Rex Medical Revolution™ Peripheral Atherectomy System when used in subjects with symptomatic infrainguinal arterial occlusive disease.

BioMimics-3D® Vascular Stent System

The BioMimics 3D Vascular Stent System has a unique 3D helical geometry which imparts a gentle helical shape to the stented artery.

3D Helical Stent Design

The BioMimics 3D Vascular Stent System has a unique 3D helical geometry which imparts a gentle helical shape to the stented artery.

Clinical evidence

The MIMICS Clinical Programme: An evolving database of the safety and effectiveness of the BioMimics 3D Vascular Stent System.